E-LIB Suche - Ergebnisse für: Matito, J.

1

49P A ctDNA tool for identifying ESR1-mutated biology in ES..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Pardo, F....
ESMO Open. 9 (2024) - p. 103056 , 2024

Link: https://doi.org/10.1016/..

2

166P Clinical use of tumor sequencing for identification of..:

Lapena, M. Cruellas ; Papakonstantinou, A. ; Castillo, E....
ESMO Open. 9 (2024) - p. 103188 , 2024

Link: https://doi.org/10.1016/..

3

Plasmatic BRAF-V600E allele fraction as a prognostic factor..:

Ros, J. ; Matito, J. ; Villacampa, G....
Annals of Oncology. 34 (2023) 6 - p. 543-552 , 2023

Link: https://doi.org/10.1016/..

4

Clinical and genomic characterization of pancreatic ductal ..:

Tissera, N.S. ; Chiaravalli, M. ; Turpin, A....
ESMO Gastrointestinal Oncology. 2 (2023) - p. 100011 , 2023

Link: https://doi.org/10.1016/..

5

13P Analytical validation of HER2DX test for early-hER2+ br..:

Torres, E. Sanfeliu ; Marín-Aguilera, M. ; Jares, P....
ESMO Open. 8 (2023) 1 - p. 101237 , 2023

Link: https://doi.org/10.1016/..

6

Interobserver variability in the classification of childhoo..:

Torrelo, A. ; Vergara‐de‐la‐Campa, L. ; Azaña, J.M....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 10 - p. 2079-2084 , 2021

Link: https://doi.org/10.1111/..

7

Characterization of CD34+ hematopoietic cells in systemic m..:

Mayado, A. ; Teodosio, C. ; Dasilva‐Freire, N....
Allergy. 73 (2018) 6 - p. 1294-1304 , 2018

Link: https://doi.org/10.1111/..

8

DualMET andERBB inhibition overcomes intratumor plasticity ..:

Martinez-Marti, A. ; Felip, E. ; Matito, J....
Annals of Oncology. 28 (2017) 10 - p. 2451-2457 , 2017

Link: https://doi.org/10.1093/..

9

Concordance of blood- and tumor-based detection of RAS muta..:

Grasselli, J. ; Elez, E. ; Caratù, G....
Annals of Oncology. 28 (2017) 6 - p. 1294-1301 , 2017

Link: https://doi.org/10.1093/..

10

Actualización en mastocitosis. Parte 2: categorías, pronóst..:

Azaña, J.M. ; Torrelo, A. ; Matito, A.
Actas Dermo-Sifiliográficas. 107 (2016) 1 - p. 15-22 , 2016

Link: https://doi.org/10.1016/..

11

Update on Mastocytosis (Part 1): Pathophysiology, Clinical ..:

Azaña, J.M. ; Torrelo, A. ; Matito, A.
Actas Dermo-Sifiliográficas (English Edition). 107 (2016) 1 - p. 5-14 , 2016

Link: https://doi.org/10.1016/..

12

Actualización en mastocitosis. Parte 1: fisiopatología, clí..:

Azaña, J.M. ; Torrelo, A. ; Matito, A.
Actas Dermo-Sifiliográficas. 107 (2016) 1 - p. 5-14 , 2016

Link: https://doi.org/10.1016/..

13

Complete response to gemtuzumab ozogamicin in a patient wit..:

Alvarez-Twose, I ; Martínez-Barranco, P ; Gotlib, J...
Leukemia. 30 (2016) 8 - p. 1753-1756 , 2016

Link: https://doi.org/10.1038/..

14

Update on Mastocytosis (Part 2): Categories, Prognosis, and..:

Azaña, J.M. ; Torrelo, A. ; Matito, A.
Actas Dermo-Sifiliográficas (English Edition). 107 (2016) 1 - p. 15-22 , 2016

Link: https://doi.org/10.1016/..

15

Cutaneous and Systemic Mastocytosis in Children: A Risk Fac..:

Matito, A. ; Carter, M.
Current Allergy and Asthma Reports. 15 (2015) 5 - p. , 2015

Link: https://doi.org/10.1007/..